Skip to content

Overcoming Barriers to HIV/AIDS Care and ART Initiation

Overcoming Barriers to HIV/AIDS Care and ART Initiation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02718456
Acronym
LINC
Enrollment
315
Registered
2016-03-24
Start date
2013-08-31
Completion date
2017-12-22
Last updated
2019-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Engagement in HIV Care

Brief summary

The study will evaluate interventions to improve engagement in HIV care following HIV diagnosis through a voluntary counseling and testing program. The specific aims are to (1) determine if a VCT-based intervention of CD4 count testing, alone or in combination with peer counseling, improves linkage to HIV/AIDS care; (2) assess the impact of the intervention on ART initiation. The study will recruit 450 HIV-positive individuals from VCTs and randomize a third to standard counseling and referral, a third to receive CD4 testing at the VCT with results return by phone after 1 weeks, and a third to receive the same CD4 testing combined with peer counseling. These combined investigations will create a comprehensive understanding of obstacles to appropriate HIV/AIDS care and result in new interventions to achieve measurable outcomes in applied settings.

Interventions

BEHAVIORALExpedited CD4 testing
BEHAVIORALSupplemental peer counseling

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years or older and * Testing HIV-positive for the first time at a voluntary counseling and testing (VCT) center. * Willing to receive counseling to encourage linkage to care at a comprehensive care center (CCC). * Willing to have a CD4 count test conducted at the enrollment visit. * Willing to have a telephone follow-up where they may receive additional counseling and/or have their CD4 count results returned to them. * Willing to be contacted over 1 year to determine if they linked to care.

Exclusion criteria

* Previous positive HIV test. * Currently taking antiretroviral medications. * Currently pregnant (females only). * Currently participating in another research study or trial. * Not planning to remain in Nairobi for the next 12 months (not including short trips out of Nairobi).

Design outcomes

Primary

MeasureTime frameDescription
Number of days from study enrollment until first visit to a comprehensive care center for HIV care.1 yearAn interviewer administered questionnaire will be used to determine if each participant visited a comprehensive care center. Is so, the date of the first visit will be recorded. From this, the time from enrollment until first visit to a comprehensive care center will be calculated.
Number of days from study enrollment until initiation of antiretroviral therapy.1 yearAn interviewer administered questionnaire will be used to determine if each participant started antiretroviral therapy. Is so, the date of treatment initiation will be recorded. From this, the time from enrollment until treatment initiation will be calculated.

Secondary

MeasureTime frameDescription
Interviewer-administered questionnaire to determine the number of visits made to a comprehensive care center for HIV care.1 yearMeasurement of the number of visits to a comprehensive care center will be made questionnaire administered in an in-person interview at 12 months after enrollment. The total number of visits will be recorded.
Measurement of CD4+ T-cell count.1 yearEach participant's CD4 count will be measure at 1 year after enrollment.

Countries

Kenya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026